View in EDS

Re-WRAP (Remyelination for women at risk of axonal loss and progression): A phase II randomized placebo-controlled delayed-start trial of bazedoxifene for myelin repair in multiple sclerosis.

Saved in:
Bibliographic Details
Title: Re-WRAP (Remyelination for women at risk of axonal loss and progression): A phase II randomized placebo-controlled delayed-start trial of bazedoxifene for myelin repair in multiple sclerosis.
Authors: Nylander A; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA., Anderson A; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA., Rowles W; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA., Hsu S; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA., Lazar AA; Division of Biostatistics, Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA., Mayoral SR; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA., Pease-Raissi SE; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA., Green A; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA., Bove R; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA. Electronic address: Riley.bove@ucsf.edu.
Source: Contemporary clinical trials [Contemp Clin Trials] 2023 Nov; Vol. 134, pp. 107333. Date of Electronic Publication: 2023 Sep 20.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37739167
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Re-WRAP (Remyelination for women at risk of axonal loss and progression): A phase II randomized placebo-controlled delayed-start trial of bazedoxifene for myelin repair in multiple sclerosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nylander+A%22">Nylander A</searchLink>; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+A%22">Anderson A</searchLink>; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rowles+W%22">Rowles W</searchLink>; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hsu+S%22">Hsu S</searchLink>; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lazar+AA%22">Lazar AA</searchLink>; Division of Biostatistics, Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mayoral+SR%22">Mayoral SR</searchLink>; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pease-Raissi+SE%22">Pease-Raissi SE</searchLink>; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Green+A%22">Green A</searchLink>; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bove+R%22">Bove R</searchLink>; University of California San Francisco, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA. Electronic address: Riley.bove@ucsf.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101242342%22">Contemporary clinical trials</searchLink> [Contemp Clin Trials] 2023 Nov; Vol. 134, pp. 107333. <i>Date of Electronic Publication: </i>2023 Sep 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101242342 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-2030 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215517144%22">15517144 </searchLink><i>NLM ISO Abbreviation: </i>Contemp Clin Trials <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37739167
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cct.2023.107333
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 107333
    Titles:
      – TitleFull: Re-WRAP (Remyelination for women at risk of axonal loss and progression): A phase II randomized placebo-controlled delayed-start trial of bazedoxifene for myelin repair in multiple sclerosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nylander A
      – PersonEntity:
          Name:
            NameFull: Anderson A
      – PersonEntity:
          Name:
            NameFull: Rowles W
      – PersonEntity:
          Name:
            NameFull: Hsu S
      – PersonEntity:
          Name:
            NameFull: Lazar AA
      – PersonEntity:
          Name:
            NameFull: Mayoral SR
      – PersonEntity:
          Name:
            NameFull: Pease-Raissi SE
      – PersonEntity:
          Name:
            NameFull: Green A
      – PersonEntity:
          Name:
            NameFull: Bove R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2023 Nov
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1559-2030
          Numbering:
            – Type: volume
              Value: 134
          Titles:
            – TitleFull: Contemporary clinical trials
              Type: main
ResultId 1